248 related articles for article (PubMed ID: 2748837)
21. Noninvasive evaluation of cerebral glioma grade by using multivoxel 3D proton MR spectroscopy.
Zeng Q; Liu H; Zhang K; Li C; Zhou G
Magn Reson Imaging; 2011 Jan; 29(1):25-31. PubMed ID: 20832225
[TBL] [Abstract][Full Text] [Related]
22. Cerebral metabolites in patients with acute and subacute strokes: concentrations determined by quantitative proton MR spectroscopy.
Mathews VP; Barker PB; Blackband SJ; Chatham JC; Bryan RN
AJR Am J Roentgenol; 1995 Sep; 165(3):633-8. PubMed ID: 7645484
[TBL] [Abstract][Full Text] [Related]
23. Differentiation between portal-systemic encephalopathy and neurodegenerative disorders in patients with Wilson disease: H-1 MR spectroscopy.
Van Den Heuvel AG; Van der Grond J; Van Rooij LG; Van Wassenaer-van Hall HN; Hoogenraad TU; Mali WP
Radiology; 1997 May; 203(2):539-43. PubMed ID: 9114118
[TBL] [Abstract][Full Text] [Related]
24. Proton MR spectroscopy after acute central nervous system injury: outcome prediction in neonates, infants, and children.
Holshouser BA; Ashwal S; Luh GY; Shu S; Kahlon S; Auld KL; Tomasi LG; Perkin RM; Hinshaw DB
Radiology; 1997 Feb; 202(2):487-96. PubMed ID: 9015079
[TBL] [Abstract][Full Text] [Related]
25. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
26. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
[TBL] [Abstract][Full Text] [Related]
27. Childhood adrenoleukodystrophy: assessment with proton MR spectroscopy.
Tzika AA; Ball WS; Vigneron DB; Dunn RS; Nelson SJ; Kirks DR
Radiology; 1993 Nov; 189(2):467-80. PubMed ID: 8210375
[TBL] [Abstract][Full Text] [Related]
28. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
Tong Z; Yamaki T; Harada K; Houkin K
Magn Reson Imaging; 2004 Jun; 22(5):735-42. PubMed ID: 15172069
[TBL] [Abstract][Full Text] [Related]
29. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy.
Shimizu H; Kumabe T; Tominaga T; Kayama T; Hara K; Ono Y; Sato K; Arai N; Fujiwara S; Yoshimoto T
AJNR Am J Neuroradiol; 1996 Apr; 17(4):737-47. PubMed ID: 8730195
[TBL] [Abstract][Full Text] [Related]
30. Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging.
Provenzale JM; McGraw P; Mhatre P; Guo AC; Delong D
Radiology; 2004 Aug; 232(2):451-60. PubMed ID: 15215555
[TBL] [Abstract][Full Text] [Related]
31. Toxoplasmosis and primary central nervous system lymphoma in HIV infection: diagnosis with MR spectroscopy.
Chinn RJ; Wilkinson ID; Hall-Craggs MA; Paley MN; Miller RF; Kendall BE; Newman SP; Harrison MJ
Radiology; 1995 Dec; 197(3):649-54. PubMed ID: 7480733
[TBL] [Abstract][Full Text] [Related]
32. Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy.
Vuori K; Kankaanranta L; Häkkinen AM; Gaily E; Valanne L; Granström ML; Joensuu H; Blomstedt G; Paetau A; Lundbom N
Radiology; 2004 Mar; 230(3):703-8. PubMed ID: 14739313
[TBL] [Abstract][Full Text] [Related]
33. Human fetal brain chemistry as detected by proton magnetic resonance spectroscopy.
Brighina E; Bresolin N; Pardi G; Rango M
Pediatr Neurol; 2009 May; 40(5):327-42. PubMed ID: 19380068
[TBL] [Abstract][Full Text] [Related]
34. [Brain tumors: interest of magnetic resonance spectroscopy for the diagnosis and the prognosis].
Sabatier J; Ibarrola D; Malet-Martino M; Berry I
Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 1):858-62. PubMed ID: 11677409
[TBL] [Abstract][Full Text] [Related]
35. Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies.
Gill SS; Thomas DG; Van Bruggen N; Gadian DG; Peden CJ; Bell JD; Cox IJ; Menon DK; Iles RA; Bryant DJ
J Comput Assist Tomogr; 1990; 14(4):497-504. PubMed ID: 2164536
[TBL] [Abstract][Full Text] [Related]
36. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
37. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
38. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
39. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques.
Arnold DL; Matthews PM; Francis GS; O'Connor J; Antel JP
Ann Neurol; 1992 Mar; 31(3):235-41. PubMed ID: 1637131
[TBL] [Abstract][Full Text] [Related]
40. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra.
Michaelis T; Merboldt KD; Bruhn H; Hänicke W; Frahm J
Radiology; 1993 Apr; 187(1):219-27. PubMed ID: 8451417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
